Cite
HARVARD Citation
Vaverkova, H. (2011). LDL-C or apoB as the best target for reducing coronary heart disease: should apoB be implemented into clinical practice?. Clinical lipidology. pp. 35-48. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vaverkova, H. (2011). LDL-C or apoB as the best target for reducing coronary heart disease: should apoB be implemented into clinical practice?. Clinical lipidology. pp. 35-48. [Online].